CLEW Collaborates With UMass Memorial Medical Center to Bring Predictive Analytics to Tele-ICUs
NETANYA, Israel, Nov. 29, 2018
NETANYA, Israel, Nov. 29, 2018 /PRNewswire/ -- CLEW, developers of an innovative, personalized clinical analytics platform optimizing the level of a patient's care, announced today its partnership with UMass Memorial Medical Center, one of the largest academic medical centers in Massachusetts.
CLEW's platform analyzes the hundreds of thousands of data points the average critical care patient in a US hospital provides every minute, to help clinicians make timely decisions with actionable clinical, operational and financial insights. The company's innovative prediction models and advanced analytics engine detects deterioration in real-time, and delivers predictive warnings during all phases of a patient's Tele-ICU stay. CLEW's AI platform will provide UMass Medical with the tools to enhance its patient care, and reduce costs by preventing clinical deteriorations, while maximizing healthcare resources.
Through this partnership, CLEW will expand its advanced clinical trials for its real-time, patient-level predictions based on AI algorithms, and customized physiological models, at UMass Memorial. These predictions will be based on clinical data leveraged from UMass Medical Center's Tele-ICUs, monitoring five different facilities, and approximately 150 patients in real-time.
"Teaming up with such a prestigious hospital is a great privilege, and we're thrilled to have CLEW's platform integrated into UMass Medical's Tele-ICU program, which will help with time sensitive decisions and creating a new standard for patient care," says Gal Salomon, CEO and Founder of CLEW.
"Electronic tools that enhance situational awareness are a key component of telemedicine support for patients and their healthcare communities," said Craig Lilly, Vice Chair of Critical Care at UMASS. "In our partnership with CLEW, I am excited to see just what these advanced tools can do within UMASS Medical Center."
About CLEW Medical
CLEW Medical (formerly Intensix), is a real time AI analytics platform designed to predict life threatening complications across various medical care settings, and help providers make better informed clinical decisions, improve outcomes and safety, streamline patient care, efficiently handle regulations and penalties, and lower the cost of care. The platform uses machine learning and data science technology to develop physiological, predictive models at the level of each individual patient in order to deliver predictive warnings during all phases of a patient's stay. Originally developed and proven in the ICU, these models optimize scarce clinical resources and guide health care providers in predicting patient deterioration, across all care settings.
CLEW Medical is headquartered in Netanya, Israel, and led by CEO Gal Salomon.
About UMass Memorial Medical Center
UMass Memorial Medical Center is the region's trusted academic medical center, part of the UMass Memorial Health Care system. We are committed to improving the health of people in Central Massachusetts through excellence in care, comprehensive health services, teaching and research.
GK for Secret Double Octopus
SOURCE CLEW Medical